Bone Biologics (BBLG) Accumulated Depreciation (2014 - 2017)
Bone Biologics (BBLG) posted quarterly Accumulated Depreciation of $357.0 for Q4 2017, up 36.78% year-over-year from $261.0 in Q4 2016, and up 7.21% quarter-over-quarter from $333.0 in Q3 2017.
Powered by 
Analysis
Bone Biologics (BBLG) Accumulated Depreciation (2014 - 2017) Analysis & Trends
Bone Biologics (BBLG) has reported Accumulated Depreciation for 4 consecutive years, with $357.0 the latest figure, recorded in Q4 2017.
- In Q4 2017, Accumulated Depreciation rose 36.78% year-over-year to $357.0; the TTM figure through Dec 2017 stood at $357.0 (up 36.78% YoY), while the FY2017 annual figure was $357.0, up 36.78% from the prior year.
- Accumulated Depreciation improved to $357.0 in Q4 2017 per BBLG's latest filing, from $333.0 in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $3982.0 in Q4 2015 and bottomed at $141.0 in Q1 2016.
- Historically, Accumulated Depreciation has averaged $816.54 across 4 years, with a median of $309.0 in 2017.
- Annual changes were most pronounced in 2015 — Accumulated Depreciation jumped 1322.14% — and 2016, when it plunged 93.45%.
- Bone Biologics' Accumulated Depreciation stood at $280.0 in 2014, then surged by 1322.14% to $3982.0 in 2015, then slumped by 93.45% to $261.0 in 2016, then jumped by 36.78% to $357.0 in 2017.
- Business Quant data shows BBLG's Accumulated Depreciation at $357.0 in Q4 2017, $333.0 in Q3 2017, and $309.0 in Q2 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 10 | Bone Biologics | 1.00 Mn | 1.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 357.00 |
| Sep 30, 2017 | 333.00 |
| Jun 30, 2017 | 309.00 |
| Mar 31, 2017 | 285.00 |
| Dec 31, 2016 | 261.00 |
| Sep 30, 2016 | 221.00 |
| Jun 30, 2016 | 181.00 |
| Mar 31, 2016 | 141.00 |
| Dec 31, 2015 | 3,982.00 |
| Sep 30, 2015 | 1,992.00 |
| Jun 30, 2015 | 1,422.00 |
| Mar 31, 2015 | 851.00 |
| Dec 31, 2014 | 280.00 |